Cargando…

Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients

PURPOSE: The purpose of our study was to analyze the characteristics of OGTT and the correlation between the insulin to C-peptide molar ratio (ICPR), HOMA-IR and insulin antibodies (IAs) in T2DM patients. PATIENTS AND METHODS: A total of 77 T2DM patients were included and divided into the IA+ group...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Kai-Fang, Zhang, Ming-You, Zhang, Yao, Ren, Bing-Jie, Wu, Yan-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375563/
https://www.ncbi.nlm.nih.gov/pubmed/35971523
http://dx.doi.org/10.2147/DMSO.S373475
_version_ 1784767991372578816
author Hua, Kai-Fang
Zhang, Ming-You
Zhang, Yao
Ren, Bing-Jie
Wu, Yan-Hui
author_facet Hua, Kai-Fang
Zhang, Ming-You
Zhang, Yao
Ren, Bing-Jie
Wu, Yan-Hui
author_sort Hua, Kai-Fang
collection PubMed
description PURPOSE: The purpose of our study was to analyze the characteristics of OGTT and the correlation between the insulin to C-peptide molar ratio (ICPR), HOMA-IR and insulin antibodies (IAs) in T2DM patients. PATIENTS AND METHODS: A total of 77 T2DM patients were included and divided into the IA+ group (25 patients) and IA- group (52 patients). The values of serum glucose, insulin, and C-peptide testing during 2-h OGTT were summarized comparatively, and ROC was made to analyze the predictive value of ICPR for IAs. RESULTS: At each time point of OGTT, there was no significant difference in serum glucose and C-peptide changes (p>0.05). Serum insulin levels in positive patients were elevated or not at different time points of the OGTT but ICPR was significantly different (P<0.05) in the two groups. Spearman correlation coefficient analysis showed that the presence of insulin antibodies was correlated with ICPR, but not with HOMA-IR, and ICPR-2h had a better prediction capacity (AUC=0.735, the optimal cutoff-point=0.11, Se=0.760, Sp=0.635). CONCLUSION: T2DM patients with IAs showed no difference in serum glucose and serum C-peptide changes, but elevated or not insulin levels on the OGTTs, compared with negative patients. ICPR-2h can be a preliminary diagnostic index to timely predict IAs in T2DM patients.
format Online
Article
Text
id pubmed-9375563
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93755632022-08-14 Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients Hua, Kai-Fang Zhang, Ming-You Zhang, Yao Ren, Bing-Jie Wu, Yan-Hui Diabetes Metab Syndr Obes Original Research PURPOSE: The purpose of our study was to analyze the characteristics of OGTT and the correlation between the insulin to C-peptide molar ratio (ICPR), HOMA-IR and insulin antibodies (IAs) in T2DM patients. PATIENTS AND METHODS: A total of 77 T2DM patients were included and divided into the IA+ group (25 patients) and IA- group (52 patients). The values of serum glucose, insulin, and C-peptide testing during 2-h OGTT were summarized comparatively, and ROC was made to analyze the predictive value of ICPR for IAs. RESULTS: At each time point of OGTT, there was no significant difference in serum glucose and C-peptide changes (p>0.05). Serum insulin levels in positive patients were elevated or not at different time points of the OGTT but ICPR was significantly different (P<0.05) in the two groups. Spearman correlation coefficient analysis showed that the presence of insulin antibodies was correlated with ICPR, but not with HOMA-IR, and ICPR-2h had a better prediction capacity (AUC=0.735, the optimal cutoff-point=0.11, Se=0.760, Sp=0.635). CONCLUSION: T2DM patients with IAs showed no difference in serum glucose and serum C-peptide changes, but elevated or not insulin levels on the OGTTs, compared with negative patients. ICPR-2h can be a preliminary diagnostic index to timely predict IAs in T2DM patients. Dove 2022-08-09 /pmc/articles/PMC9375563/ /pubmed/35971523 http://dx.doi.org/10.2147/DMSO.S373475 Text en © 2022 Hua et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hua, Kai-Fang
Zhang, Ming-You
Zhang, Yao
Ren, Bing-Jie
Wu, Yan-Hui
Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients
title Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients
title_full Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients
title_fullStr Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients
title_full_unstemmed Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients
title_short Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients
title_sort characteristics of ogtt and correlation between the insulin to c-peptide molar ratio, homa-ir, and insulin antibodies in t2dm patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375563/
https://www.ncbi.nlm.nih.gov/pubmed/35971523
http://dx.doi.org/10.2147/DMSO.S373475
work_keys_str_mv AT huakaifang characteristicsofogttandcorrelationbetweentheinsulintocpeptidemolarratiohomairandinsulinantibodiesint2dmpatients
AT zhangmingyou characteristicsofogttandcorrelationbetweentheinsulintocpeptidemolarratiohomairandinsulinantibodiesint2dmpatients
AT zhangyao characteristicsofogttandcorrelationbetweentheinsulintocpeptidemolarratiohomairandinsulinantibodiesint2dmpatients
AT renbingjie characteristicsofogttandcorrelationbetweentheinsulintocpeptidemolarratiohomairandinsulinantibodiesint2dmpatients
AT wuyanhui characteristicsofogttandcorrelationbetweentheinsulintocpeptidemolarratiohomairandinsulinantibodiesint2dmpatients